Basecamp Research raises a $140 million Series C led by S32 to train new EDEN models and advance AI-designed therapeutics

Basecamp Research announced an oversubscribed $140 million Series C led by S32, with NVIDIA, Menlo Ventures' Anthology Fund, Catalio Capital Management and others. Funding is for a pipeline of EDEN-designed therapeutics, starting with in vivo cell therapy, and for expanding pharma partnerships. Announced 23 September 2026 (company page); added as an older item that Community lacked.